Biological Industries Releases Human Mesenchymal Stem Cell Differentiation Kits for Health Therapies

Biological Industries (BI), a worldwide leader in the design and manufacture of life science products for the biopharmaceutical industry, has launched innovative hMSC differentiation kits for research and stem cell based therapies.

This is a unique line of serum-free and xeno-free differentiation kits, providing the ability to efficiently differentiate hMSC from various sources into adipocytes, chondrocytes and osteoblasts, said David Fiorentini, Director of Research & Development.

All three kits are serum free and xeno free:

MSC Go Osteogenic XF - Rapid differentiation of osteogenic (Complete, ready-to-use)

MSC Go Adipogenic XF -Basal medium and supplements mix

MSC Go Chondrogenic XF -Basal medium and supplement mix

The Differentiation media contain all the growth factors and supplements necessary for the direct differentiation of hMSC, Fiorentini said.

The kits are designed to be user friendly with all necessary ingredients included. They offer a complete system for multipotency evaluation of hMSCs and reliable induction of hMSCs into adipocytes, chondrocytes and osteoblasts/osteocytes. No adaptation is required from cell expansion cultures using MSC NutriStem XF Medium.

The kits were validated for hMSC from various tissues including BM-hMSC, AT-hMSC, and UCT-hMSC.

BIs previous release was the MSC NutriStem XF Medium, a gold standard serum-free, xeno-free medium developed for the growth and expansion of human mesenchymal stem cells (hMSC) isolated from a variety of sources including bone marrow, adipose tissue and umbilical cord tissue; BM-hMSC, AT-hMSC, UCT-hMSC.

See the article here:
Biological Industries Releases Human Mesenchymal Stem Cell Differentiation Kits for Health Therapies